OrbusNeich Medical Group Holdings Investor Relations
OrbusNeich Medical Group Holdings Earnings Call Summary
Earnings Call Summary
A brief overview of the key points discussed during a company’s quarterly earnings call, including financial performance, guidance, and management’s commentary on future outlook.
OrbusNeich Medical Group Holdings Earnings
Estimates
Actual
Y-on-Y Change
Revenue
EPS
Transcripts
Events
About OrbusNeich Medical Group Holdings Limited
O
O
OrbusNeich Medical Group Holdings Limited
6929
OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expandable stent system. Its product portfolio covers various treatment processes in percutaneous coronary intervention and percutaneous transluminal angioplasty procedures. It operates in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.
OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons...
OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expandable stent system. Its product portfolio covers various treatment processes in percutaneous coronary intervention and percutaneous transluminal angioplasty procedures. It operates in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.
Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach. Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.